BioSpace News Archive

Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and Chairman, is scheduled to participate in a fireside chat at the Cantor Virtual Global Healthcare Conference

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy, announced today that Jordan Dubow, M.D. will be stepping down as Chief Medical Officer to pursue another opportunity

Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), today announced that it will host a virtual Key Opinion Leader (KOL) event to review new interim data presented from the ongoing Phase 2 ACCURACY study of AL101 for the treatment of recurrent/metastatic (R/M) adenoid cystic carcinoma

Today Allergan Aesthetics, an AbbVie company (NYSE: ABBV), and Skinbetter Science® announced the launch of a new long-term, educational initiative – DREAM: Driving Racial Equity in Aesthetic Medicine™.

Agendia, Inc. a world leader in precision oncology for breast cancer today announced that new clinical data from its ongoing research in breast cancer is to be presented at the upcoming European Society for Medical Oncology (ESMO) Virtual Congress 2020, September 19-21

Sanolla, [Formerly: Bat-Call] an Israeli medical device and technology start-up driving artificial intelligence (AI) based innovations in acoustic digital diagnostic systems and healthcare platforms, has been granted EU funding under the Horizon 2020 program to help tackle the ongoing coronavirus (COVID-19) pandemic.

Company Continues Support for The American Nephrology Nurses Association (ANNA) to Help Advance Practice of Nephrology Nursing Through Engagement and Education

The new professional doctorate aligns with the American Association of Colleges of Nursing’s vision to provide an additional terminal nursing degree option

Orexo AB (publ.), (STO:ORX) (OTCQX:ORXOY) today announces it has filed a patent infringement action in the United States District Court for the District of New Jersey with docket number 3:20-cv-12588, against Sun Pharmaceutical Industries Limited, Sun Pharma Global FZE, Sun Pharma Global, Inc., and Sun Pharmaceutical Indu

Teva to Present New Data at The MDS Virtual Congress 2020 and Psych Congress 2020 Virtual Experience Evaluating Long-Term Treatment with AUSTEDO ® (deutetrabenazine) Tablets Additional data to be presented examining the safety and tolerability of AUSTEDO during periods of titration and maintenance JERUSALEM & PARSIPPANY, N.J.--( BUSINESS WIRE )-- Teva Neuroscience, Inc., an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA)